Biochemical Markers for the Prediction of Preterm Delivery

National Vital Statistics Reports. September 29, 2006. Volume 55:1. National Vital Statistics Reports. June 13, 2007. Volume 55:14. Garite, 2004, Premature rupture of the membranes, 723 Holbrook, 1989, Evaluation of a risk-scoring system for prediction of preterm labor, Am J Perinatol, 6, 62, 10.1055/s-2007-999547 Honest, 2003, Electronic searching of the literature for systematic reviews of screening and diagnostic tests for preterm birth, Eur J Obstet Gynecol Reprod Biol, 107, 19, 10.1016/S0301-2115(02)00265-8 Lockwood, 1993, New approaches to the prediction of preterm delivery, J Perinat Med, 21, 441 Goldenberg, 2002, The management of preterm labor, Obstet Gynecol, 100, 1020, 10.1016/S0029-7844(02)02212-3 Ascarelli, 1997, Use of fetal fibronectin in clinical practice, Obstet Gynecol Surv, 53, S1, 10.1097/00006254-199704000-00024 Lockwood, 1993, The presence of cervical and vaginal fetal fibronectin predicts preterm delivery in an inner city obstetric population, Am J Obstet Gynecol, 169, 798, 10.1016/0002-9378(93)90008-7 Lockwood, 1991, Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery, N Engl J Med, 325, 669, 10.1056/NEJM199109053251001 Feinberg, 1991, Is oncofetal fibronectin a trophoblast blue for human implantation?, Am J Pathol, 138, 537 Yeast, 2004, A positive fetal fibronectin test is associated with a reduced risk of failed induction, Obstet Gynecol, 103, 70S Morrison, 1993, Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery, Am J Obstet Gynecol, 168, 538, 10.1016/0002-9378(93)90488-5 Iams, 1995, Fetal fibronectin improves the accuracy of diagnosis of preterm labor, Am J Obstet Gynecol, 173, 141, 10.1016/0002-9378(95)90182-5 Peaceman, 1997, Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial, Am J Obstet Gynecol, 177, 13, 10.1016/S0002-9378(97)70431-9 Lopez, 2000, Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice, Am J Obstet Gynecol, 182, 1103, 10.1067/mob.2000.105411 Lukes, 1997, Predictors of positivity for fetal fibronectin in patients with symptoms of preterm labor, Am J Obstet Gynecol, 176, 639, 10.1016/S0002-9378(97)70561-1 Nageotte, 1994, Fetal fibronectin in patients at increased risk for premature birth, Am J Obstet Gynecol, 170, 20, 10.1016/S0002-9378(94)70376-0 Hellemans, 1995, Fetal fibronectin detection for prediction of preterm birth in low risk women, Br J Obstet Gynaecol, 102, 207, 10.1111/j.1471-0528.1995.tb09095.x Garcia, 1999, Presence of fetal fibronectin in cervico-vaginal secretion as predictor of premature labor, Genecol Obstet Mex, 67, 23 Sakai, 2003, The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes, Obstet Gynecol, 101, 123, 10.1016/S0029-7844(02)02463-8 Goldenberg, 1996, The Preterm Prediction Study: fetal fibronectin testing and spontaneous preterm birth, Obstet Gynecol, 87, 643, 10.1016/0029-7844(96)00035-X Honest, 2002, Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review, BMJ, 325, 1, 10.1136/bmj.325.7359.301 Challis, 1996, Control of parturition, Prenat Neonat Med, 1, 283 Liggins, 1989, Initiation of labor, Biol Neonat, 55, 366, 10.1159/000242940 Nathanielsz, 1998, Comparative studies on the initiation of labor, Eur J Obstet Gynecol Reprod Biol, 78, 127, 10.1016/S0301-2115(98)00058-X Garfield, 1998, Control of myometrial contractility: role and regulation of gap junctions, Oxf Rev Reprod Biol, 10, 436 Norwitz, 1999, The control of labor, N Engl J Med, 341, 660, 10.1056/NEJM199908263410906 Goodwin, 1999, A role for estriol in human labor, term and preterm, Am J Obstet Gynecol, 180, S208, 10.1016/S0002-9378(99)70702-7 Darne, 1987, Saliva oestriol, oestradiol, oestrone and progesterone levels in pregnancy: spontaneous labour at term is preceded by a rise in salivary oestriol:progesterone ratio, Br J Obstet Gynaecol, 94, 227, 10.1111/j.1471-0528.1987.tb02359.x Moran, 1992, Lack of normal increase in saliva estriol/progesterone ratio in women with labor induced at 42 weeks' gestation, Am J Obstet Gynecol, 167, 1563, 10.1016/0002-9378(92)91740-2 Vining, 1983, Saliva estriol measurements: an alternative to the assay of serum unconjugated estriol assessing feto-placental function, J Clin Endocrinol Metab, 56, 454, 10.1210/jcem-56-3-454 Voss, 1999, Saliva as a fluid for measurement of estriol levels, Am J Obstet Gynecol, 180, 226, 10.1016/S0002-9378(99)70706-4 Hull, 1978, Plasma unconjugated oestriol in late pregnancy: circadian variation and the effect of meals and a glucose load, Br J Obstet Gynaecol, 85, 645, 10.1111/j.1471-0528.1978.tb14941.x McGregor, 1999, Diurnal variation in saliva estriol during pregnancy: a pilot study, Am J Obstet Gynecol, 180, S223, 10.1016/S0002-9378(99)70705-2 Hendershott, 1996, Serial betamethasone administration and the effect on maternal salivary estriol levels, J Soc Gynecol Invest, 3, 276A, 10.1016/1071-5576(96)82883-8 Leff, 2002, The effect of betamethasone on salivary estriol, J Matern Fetal Neonatal Med, 11, 192, 10.1080/jmf.11.3.192.195 McGregor, 1995, Salivary estriol as risk assessment for preterm labor: a prospective trial, Am J Obstet Gynecol, 173, 1337, 10.1016/0002-9378(95)91383-1 Heine, 1999, Accuracy of salivary estriol compared to traditional risk factor assessment in predicting preterm birth, Am J Obstet Gynecol, 180, S214, 10.1016/S0002-9378(99)70703-9 Heine, 2000, Serial salivary estriol to detect an increased risk of preterm birth, Obstet Gynecol, 96, 490, 10.1016/S0029-7844(00)01004-8 Majzoub, 1999, A central theory of preterm and term labor: putative role for corticotropin-releasing hormone, Am J Obstet Gynecol, 180, S232, 10.1016/S0002-9378(99)70707-6 McLean, 1995, A placental clock controlling the length of human pregnancy, Nat Med, 1, 460, 10.1038/nm0595-460 Berkowitz, 1996, Corticotropin-releasing factor and its binding protein: maternal serum levels in term and preterm deliveries, Am J Obstet Gynecol, 174, 1477, 10.1016/S0002-9378(96)70591-4 Wadha, 1998, Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy, Am J Obstet Gynecol, 179, 1079, 10.1016/S0002-9378(98)70219-4 Wadha, 2004, Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation, Am J Obstet Gynecol, 191, 1063, 10.1016/j.ajog.2004.06.070 Korebrits, 1998, Maternal corticotrophin-releasing hormone is increased with impending preterm birth, J Clin Endocrinol Metab, 83, 1585, 10.1210/jc.83.5.1585 Bisits, 1998, Corticotropin-releasing hormone: a biochemical predictor of preterm delivery in a pilot randomized trial of the treatment of preterm labor, Am J Obstet Gynecol, 178, 862, 10.1016/S0002-9378(98)60503-2 Warren, 1992, Elevated maternal plasma corticotropin-releasing hormone levels in pregnancies complicated by preterm labor, Am J Obstet Gynecol, 166, 1198, 10.1016/S0002-9378(11)90606-1 Makrigiannakis, 2007, Maternal serum corticotropin-releasing hormone and ACTH levels as predictive markers of premature labor, Internat J Gynecol Obstet, 97, 115, 10.1016/j.ijgo.2007.01.007 Goldenberg, 2000, Intrauterine infection and preterm delivery, N Engl J Med, 342, 1500, 10.1056/NEJM200005183422007 Katz, 1990, Unexplained elevations of maternal serum alpha-fetoprotein, Obstet Gynecol Surv, 45, 719, 10.1097/00006254-199011000-00001 Gonen, 1992, The association between unexplained second-trimester maternal serum HCG elevation and pregnancy complications, Obstet Gynecol, 80, 83 Onderoglu, 1997, Elevated second trimester human chorionic gonadotropin level associated with adverse pregnancy outcome, Int J Gynecol Obstet, 56, 245, 10.1016/S0020-7292(96)02830-5 Sanchez-Ramos, 2003, Human chorionic gonadotropin in cervicovaginal secretions as a predictor of preterm delivery, Int J Gynaecol Obstet, 83, 151, 10.1016/S0020-7292(03)00273-X Wenstrom, 1996, Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein, Obstet Gynecol, 87, 213, 10.1016/0029-7844(95)00377-0 Morssink, 1998, Maternal serum levels of free beta-HCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery, Prenat Diagn, 18, 147, 10.1002/(SICI)1097-0223(199802)18:2<147::AID-PD231>3.0.CO;2-W Verspyck, 1999, Amniotic fluid alpha-fetoprotein is not a useful biological marker of pregnancy outcome, Prenat Diagn, 19, 1031, 10.1002/(SICI)1097-0223(199911)19:11<1031::AID-PD684>3.0.CO;2-7 van Rijn, 1999, Adverse obstetric outcome in low- and high- risk pregnancies: predictive value of maternal serum screening, Obstet Gynecol, 94, 929, 10.1016/S0029-7844(99)00467-6 Gurbuz, 2004, Human chorionic gonadotropin assay in cervical secretions for accurate diagnosis of preterm labor, Int J Gynaecol Obstet, 85, 132, 10.1016/j.ijgo.2003.10.007 Plevyak, 2003, Concentrations of serum total activin A and inhibin A in preterm and term labor patients: a cross-sectional study, J Soc Gynecol Investig, 10, 231, 10.1016/S1071-5576(03)00047-9 Petersen, 1992, Serum relaxin as a potential marker for preterm labour, Br J Obstet Gynaecol, 92, 292, 10.1111/j.1471-0528.1992.tb13725.x Wallace, 1996, Inhibins and activins: roles in clinical practice, Br J Obstet Gynaecol, 103, 945, 10.1111/j.1471-0528.1996.tb09541.x Akers, 2007, Fibronectin assays and histological evidence of acute placental inflammation, J Perinatal Med, 35, 36, 10.1515/JPM.2007.005 Mercer, 2006, Are women with recurrent spontaneous preterm lbirths different from those without such history?, Am J Obstet Gynecol, 194, 1176, 10.1016/j.ajog.2006.01.069 Mateus, 2007, Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions, Am J Perinatol, 24, 381, 10.1055/s-2007-981849 Singer, 2007, Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor, Obstet Gynecol, 109, 1083, 10.1097/01.AOG.0000261896.20175.3a Goldenberg, 2007, Fetal fibronectin and adverse infant outcomes in a predominant human immunodeficiency virus-infected African population: a randomized controlled trial, Obstet Gynecol, 109, 392, 10.1097/01.AOG.0000247628.68415.00 Schmitz, 2006, Selective use of fetal fibronectin detection after cervical length measurement to predict spontaneous preterm delivery in women with preterm labor, Am J Obstet Gynecol, 194, 138, 10.1016/j.ajog.2005.05.074 Gomex, 2005, Cervicovaginal fibronectin improves the prediction of preterm delivery based on sonographic cervical length in patients with preterm uterine contractions and intact membranes, Am J Obstet Gynecol, 193, 308